Critical dynamics of gene networks is a mechanism behind ageing and Gompertz law

D. Podolskiy1, I. Molodtcov2,3, A. Zenin3, V. Kogan2,3, L. I.Menshikov3, Robert J. Shmookler Reis4,5,6 & P. O. Fedichev2,3

1)Massachusetts Institute of Technology, 77 Massachusetts Ave., Cambridge, MA, 02139, USA2)Moscow Institute of Physics and Technology, 141700,

Institutskii per. 9, Dolgoprudny, Moscow Region, Russian Federation,3)Quantum Pharmaceuticals Ltd, Ul. Kosmonavta Volkova 6A-1205, 125171, Moscow, Russian Federation,

4)McClellan VA Medical Center, Central Arkansas Veterans Healthcare System, Little Rock, AR, USA5)Department of Biochemistry and Molecular Biology,

University of Arkansas for Medical Sciences, Little Rock, AR, USA and6)Department of Geriatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Although it has long been suggested that accumulation of errors in transcription and translationis one of the most important molecular mechanisms leading to ageing, a quantitative link betweenthe error accumulation dynamics and mortality of species has so far remained elusive. We studystability properties of a generic gene regulatory network (GRN) and demonstrate that phenomenol-ogy of ageing and the associated population mortality rate can be naturally described in terms ofcritical dynamics of gene regulation and metabolic profiles. We analyze age-dependent microarraydatasets and metabolic profiles for Drosophila melanogaster and explicitly show that the resultingGRNs are nearly critical and inherently unstable. This instability manifests itself as ageing in theform of exponential distortions of gene expressions and metabolic profiles with age, and causes thecharacteristic increase in mortality rate with age as described by the Gompertz law. On top ofthat we explain the plateau in mortality rates observed at very late ages for large populations. Weshow that ageing contains both a stochastic component, related to regulatory error accumulation intranscription/translation/metabolic pathways, and a strong deterministic component, which can benaturally associated with a part of a development programme. We conclude on this basis that twoopposing hypotheses of ageing, error accumulation and programmed ageing are in fact compatiblewith each other. Since mortality in humans, where it is characterized best, is mostly associated withage related diseases, we support the idea of ageing being the driving force behind the developmentof major diseases.

INTRODUCTION

Ageing is a complicated interplay of different processesin a living matter. The processes influenced by and af-fecting ageing take place at every possible scale character-izing the living organism, ranging from a single cell level(e.g., oxidative damage to cells, or somatic mutations)to the level of interaction between different body organs(e.g., failure of individual organs with age or accumula-tion of dangerous byproducts of metabolic activity suchas arterial plaque). This is why it has been notoriouslydifficult to pinpoint the ultimate cause, a single molec-ular mechanism behind ageing and relate it to such life-long consequences as progression of chronic age-relateddiseases and, ultimately, mortality. As a consequence, awide spectrum of propositions on the origin of ageing hasemerged over the years such as the hypothesis of dam-age accumulation [1–4], the hyperfunction theory [5, 6],the disposable soma hypothesis [7, 8] and antagonisticpleiotropy [9]. Since the theories of ageing, often verydifferent from each other in both spirit and letter, reflectupon different “facets” of ageing [10], it is not always pos-sible to see their mutual inconsistencies and compatibili-ties. In particular, there seems to exist a major collisionbetween theories that view ageing as a pre-programmedprocess [5, 6, 11–13] or a stochastic process associatedwith damage/error accumulation [1–4]. We shall arguehere that these two ideas are in fact fully compatible

with each other.The argument is based on the hypothesis suggested

nearly 40 years ago by Leslie Orgel [14] (see also [15, 16]),that one of the molecular-level processes responsiblefor ageing is the accumulation of translation and tran-scription errors in cells, exceeding the ability of cellulardamage-response pathways to repair. Recently we haveperformed a semi-quantitative study of a generic GRNstability and suggested a causal relation between the ac-cumulation of the regulatory errors, mortality increaseand ageing [17]. However, the underlying mechanisticlevel details of the interplay between the dynamics of er-ror accumulation in transcription/translation/metabolicprocesses and the increase in mortality rates has not yetbeen clearly established.

To identify such a link, we develop a theory of stochas-tic critical dynamics of GRN and show, that under verygeneric assumptions, GRNs of most species are inher-ently unstable. Applying the method of proper orthog-onal decomposition common in “Big Data” analysis [18]to the publicly available age-variable transcriptome andmetabolome datasets for Drosophila melanogaster [19,20], we demonstrate explicitly, that the auto-correlationfunctions of transcriptional and metabolic datasets forD. melanogaster exhibit stochastic exponential instabil-ity with a characteristic time scale, tα, which is of thesame order as mortality rate doubling time tMRDT ofD. melanogaster. We provide explicit solutions for the

arX

iv:1

502.

0430

7v1

[q-

bio.

MN

] 1

5 Fe

b 20

15

2

stochastic ageing dynamics of realistic GRNs, obtain ex-pressions for age-dependent mortality increase. We arguethat the two time scales, tα and tMRDT, should coincidefor any other species subject to Gompertz mortality law.Therefore we are able to causally relate the GRN insta-bility to the characteristic Gompertzian increase of mor-tality rate in populations. The exponential increase ofmortality eventually slows down and the mortality rate isexpected to approach a plateau, M(t & tls) ∼ 1/tMRDT,at late ages, where tls is the mean lifespan of the species.The result should be valid for sufficiently long lived an-imals, tls � tα and appears to be new. The predic-tion is confirmed by our analysis of the transcriptomes,metabolomes and mortality curves for populations of D.melanogaster on sugar-rich diets and mortality curves forvery large cohorts of medflies [21]. We establish spe-cific metabolites and genes as be biomarkers of ageingin D. melanogaster, the respective human orthologs, andprovide their associations with genes and pathways com-monly related to the major diseases of elders.

We show that the dynamics of ageing, as manifestedin transcriptional and metabolic profiles, contains botha stochastic component, related to regulatory error ac-cumulation in transcription/translation/metabolic path-ways, and a strong deterministic component, which canbe naturally associated with a development programmeand leads to ageing in a form of hyperfunction. We con-clude on this basis that the error accumulation and theprogrammed ageing hypotheses may, in fact, be compat-ible with each other. We show the presented model mayserve to embrace most of the known features of the ageingprocesses and hence can emerge as a novel and universalway for quantitative ageing characterization. We believethat the theoretical ideas presented in the Letter be use-ful in identification of biomarkers and, after a proper de-velopment, mechanistic level processes regulating ageingin any sufficiently long lived organisms.

RESULTS

Age-associated stochastic dynamics oftranscriptional and metabolic profiles. Quantitative

model of ageing

In this Section we first explain the theoretical basis forour quantitative analysis of transcriptional and metabolicprofile changes with age and construct the quantitativemodel of ageing. We consider the case of a gene reg-ulatory network (GRN in what follows) described by ageneric set of non-linear matrix equations of systems bi-ology, f

(x, dx/dt, d2x/dt2, ...

)= F . Here f is a vec-

tor function of any number of quantities representing thestate of the system, x, and its time derivatives, whichcharacterizes the interactions between different compo-nents of x, and the vector F describes the action of mostlystochastic external or endogenous stress factors affectingthe gene expression levels. If, for example, the state vec-

tor x consists of the gene expression levels only, as in e.g.[19], the functions f may be thought as encoding path-ways, which the given genes contribute to. The vectorF may depend on time, t: F (t) = F0 + δF (t), where F0

and δF represent the mean stress and the fluctuations ofstress levels, respectively. In addition to gene expressionlevels, the state vector x may include other descriptors,[19], such as levels of metabolites [20] or methylation lev-els on CpG sites [22]. As the system state vector x isnot observable in its entirety, we presume that any suf-ficiently large part of it captures a sufficient amount ofinformation about the biological system state (and thedynamics of ageing).

Over long times, gene expression levels typically fluctu-ate near certain, relatively slowly changing, mean values,corresponding to the homeostatic state of an organism.Therefore, we assume that there always exists a quasi-stationary point x0 (homeostasis of the organism), givenby the solution of the stationary equation f(x0) = F0. Asa result, the slow dynamics of the fluctuations of the geneexpression levels, δx = x−x0, follows in its leading orderthе matrix stochastic equation of a linear (continuum-limit) Markov chain:

Dδx+Kδx = δF, (1)

where the matrices D and K correspondingly describethe dynamical relaxation properties of the gene expres-sion levels and the interactions between the componentsof the gene regulatory network (see Supplementary In-formation, Section A for the in-depth derivation of Eq.(1)).

It has been previously suggested that in most speciesGRNs operate close to a stability-instability or order-disorder bifurcation [23, 24]. The transition from sta-bility to instability in networks with network graphsnot possessing specific symmetries is typically associatedwith existence of co-dimension 1 bifurcations [25, 26].Such transitions are characterized by the loss of stabilityalong a single principal component of the network statevector, while contributions from all other principal com-ponents remain stable. This situation, known in the lit-erature as a saddle-node bifurcation [25], is realized whenthe lowest (real) eigenvalue, ε, of the regulatory networkmatrix K reaches zero, ε → 0, and then becomes nega-tive. Accordingly, the stationary solution for x0 ceases toexist, and the homeostatic state of the organism starts tochange in time. As we shall argue, this very instabilitymay be directly responsible for the process of ageing.

As explained in Supplementary Information A, closeto the co-dimension 1 bifurcation point the dynamics ofthe gene expression levels δx becomes critical. This im-plies that fluctuations of the expressome δx are stronglyamplified with age, the phenomenon known as criticalslowing-down, see e.g. [27]. In particular, the autocor-relation time scale tauto = (aT ·Db)/ε of the expressomediverges at ε → 0, implying that stochastic dynamicsof δx becomes very slow near the point of bifurcation.The fluctuations of the expressome state vector δx in-

3

A

z

V(z)

α>0 α<0

B

0 20 40 60 80

0

0.5

1

1.5

2

age,daysz

i2,

arb

itra

ry u

nits

transcriptome, i=1

transcriptome, i=2

metabolome, i=1

metabolome, i=2

Figure 1: (A) Schematic representation of the stochastic dynamics in the effective potential V (z) corresponding tothe cases of stable (α > 0) and unstable (α < 0) GRNs, see Eq. (2). (B) Age dependence of the variance, E(z2

1,2),z1,2 = (δxT · b1,2), i = 1, 2, of the expressome state projections onto the first two principle component vectors b1,2 asfunctions of age (gene expressions from [19], red, and metabolites levels from [20], blue). Here E(...) stands for the

average over the biological repeats; (aT · b) denotes a scalar product of two vectors a and b.

cluding those created in response to persistent externalstress are mostly amplified along the direction b of theright eigenvector of K corresponding to the vanishingeigenvalue ε[28]. This, in turn, guarantees, that over verylong times comparable to the average lifespan the geneexpression dynamics is dominated by the single princi-pal component collinear with the direction of the vectorb. We conclude that the fluctuations of the GRN statevector δx evolving over long intervals of time can be ac-curately described with the help of a single variable z,such that δx ≈ z · b. Accordingly, Eq. (1) can be reducedto the equation

dz

dt+∂V (z)

∂z= f, (2)

describing the Brownian motion of a particle in an ef-fective potential V (z) ≈ −αz2/2, where the quantityα = −ε/(aT · Db) characterizes the “stiffness” of thegene regulatory network. The stochastic force, f =(aT ·δF )/(aT ·Db), is a single unified quantitative measureof all external and endogenous “genotoxic” stress, and ischaracterized by the diffusion coefficient ∆ (see Supple-mentary Information A for the in-depth derivation anddiscussion).

Depending on the specific morphological properties ofthe gene regulatory network, the curvature of V (z) at

small z can be negative, α < 0, or positive, α > 0, asshown on Figure 1A. In the latter case, the GRN is in-herently unstable, and the variance of the gene expres-sion levels, C(t), computed using the solutions of Eq. (2)grows exponentially with age as

C(t) = E(δx(t)δxT (t)) ≈ E(δx20)b · bT exp(2αt). (3)

The expression (3) is fully consistent with earlier observa-tion of increasing biological variability with age [29, 30].

Criticality of the dynamics of gene expression levelsimplies that the parameter α is small and hence the co-variance matrix C(t) of the expressome should be verysingular. The right eigenvector of the covariance matrixcorresponding to its largest eigenvalue coincides in thiscase with the right eigenvector b of the matrix K corre-sponding to vanishing eigenvalue ε→ 0 (see Supplemen-tary Information, Section A).

These conclusions are supported by Principal Com-ponents Analysis (PCA) of the age-dependent shifts ofRNA transcript and metabolite levels in D. melanogasterfrom [19] and [20], respectively. The covariance matricescomputed from such datasets are indeed very singular,see Supplementary Information, Figure 4. This meansthat the dynamics of the state vector δx is dominated bythe variance along the first principal component, z ≡ z1,

4

A

0 20 40 60 8010

−4

10−2

100

mo

rta

lity r

ate

, d

ays

−1

age,days

tls

=26 days

0 20 40 60 8010

−4

10−2

100

z12,

arb

itra

ry u

nits

mortality rate

z1

2

B

0 5000 10000−0.3

−0.2

−0.1

0

0.1

0.2

ib

i

Pe

bII

I

CG

32

95

0

Pe

pck

Mtn

A

Lvp

H

CG

15

06

8

de

sa

t1

IM3

Drs

Fe

r2L

CH

Vm

34

Ca

Cp

16

Vm

26

Aa

Cp

19

Se

r4

Cp

38

Vm

26

Ab

Cp

36

Cp

18

Cp

15

C

0 20 40 60 8010

−4

10−2

100

mo

rta

lity r

ate

, d

ays

−1

age,days

tls

=42 days

0 20 40 60 8010

−4

10−2

100

z12,

arb

itra

ry u

nits

mortality rate

z1

2

D

0 50 100 150 200−0.4

−0.2

0

0.2

0.4

0.6

0.8

1

i

bi

be

tain

e

his

tid

ine

ph

osp

ho

ch

olin

e

ace

tylc

arn

itin

e

C3

2:2

PC

pro

pio

nylc

arn

itin

e

C3

6:2

PC

C5

0:1

TA

G

C3

0:1

PC

C3

2:1

PC

arg

inin

e

myristo

ylc

arn

itin

e

C3

4:2

PC

ca

rnitin

e

alp

ha

−g

lyce

rop

ho

sp

ho

ch

olin

e

Figure 2: Basic biological evidence for the presented stochastic model of ageing: (A) The mortality along with theprojection z of the system state vector, δx, represented by the transcriptomes of ageing D. melanogaster [19], ontothe singular direction b of the covariance matrix E(δx(t)δxT (t′)) as a function of age. (B) Components of the vectorb for D. melanogaster, analysis of age-associated changes in transcriptional profiles only. Peaks correspond to the

values of the components of the vector b for every gene in the dataset. (C) The mortality and the projection z of thesystem state vector δx, represented by the metabolomes of ageing D. malanogaster [20]; (D) Components of the

vector b for D. melanogaster, computed using the levels of targeted metabolites only [20].

5

pos neg

response to inorganic substance

response to stress

oxidation-reduction process

organic acid metabolic process

reactive oxygen species metabolicprocess

carbohydrate metabolic process

humoral immune response

hydrogen transport

egg coat formation

eggshell formation

cell wall organization or biogenesis

generation of precursor metabolites andenergy

ion transport

transmembrane transport

protein localization to endoplasmicreticulum

extracellular structure organization

organophosphate metabolic process

anatomical structure formation involvedin morphogenesis

inorganic ion transmembrane transport

nucleoside monophosphate metabolicprocess

protein folding

multi-organism process

mitochondrial electron transport,cytochrome c to oxygen

ATranscript GO enrichmentFrequency

2%4%6%8%10%

3

4

5

6

7

8

9

10

pos neg

Oxidative phosphorylation

Neuroactive ligand-receptor interaction

Pyruvate metabolism

Biosynthesis of unsaturated fatty acids

CKEGG enrichment

2

3

4

5

6

7

8

9

10

11

-log10(p-value)

mitochondrial electron transport chainpurine metabolism

protein biosynthesisurea cycle

citric acid cyclemethionine metabolismpyrimidine metabolism

glycerol phosphate shuttleammonia recycling

glutamate metabolismrna transcription

betaine metabolism

B Metabolome enrichment

1.05

1.20

1.35

1.50

1.65

1.80

1.95

2.10

-log10(p-value)

pos neg

Parkinson's disease

Alzheimer's disease

Huntington's disease

Oxidative phosphorylation

Cardiac muscle contraction

Pyruvate metabolism

PPAR signaling pathway

Glycine, serine and threonine metabolism

DHuman orthologs KEGG enrichment

5.6

6.0

6.4

6.8

7.2

7.6

8.0

-log10(p-value)

Figure 3: Biological characterization of the “leading direction of ageing” b in D. melanogaster : (A) Gene Ontologies(Biological Process only) enrichment by the leading positive and negative components of the vector b computedusing the gene expressions; (B) Metabolite set enrichment for the leading components of the vector b computed

using the levels of targeted metabolites; (C) KEGG pathways enrichment by the gene sets representing the leadingcomponents of b, corresponding to positively and negatively regulated genes; (D) KEGG pathways enrichment by

human orthologs of the ageing direction in fruit flies.

where PC1 = (δxT · b1), as described on Figure 1B. Thevariance along PC1 grows exponentially with age, bothin metabolome and in the transcriptome, in accordancewith Eq. (3). The exponent, roughly inferred from eachof the datasets for ages less than the mean lifespan, ap-pears to be nearly constant, which is an indication of thesame GRN instability observed in each of the measure-ments. For the sake of comparison, we have also plottedprojections of the gene expressions on the next principal

component, PC2. It is easy to see that the transcrip-tome remains dynamically stable along PC2, exactly asexpected from an unstable GRN near a co-dimension 1saddle-node bifurcation, governed by Eq. (2). We thusconclude that at the origin, z ≈ 0, the expressome statecorresponds to a healthy or a “youthful” state, while thelarger values of z phenotypically describe transcription-ally distorted states of aged animals. Accordingly, age-ing manifests itself as a slow dynamics of gene expression

6

levels, a “simple” exponential roll-out along the singular,or “ageing” direction b, from the younger animals to theolder ones. The singular “direction of ageing” b is associ-ated with a response to a generic stress and determinedby the properties of the gene interactions only. Since, atleast within the model assumptions, the direction b doesnot depend on the genotoxic stress factors and appears tohard-coded in the genome, the development of an organ-ism along “the direction of ageing” b may be said to begoverned by a gene-encoded program (or a quasi-program[31–34]).

Gompertz mortality law and biological age.

To causally relate the GRN instability with the pro-cess of ageing we further assume, in a way consistentwith hyperfunction hypothesis [5], that for every gene inthe genome there exists a particular threshold Zi of itsexpression, which is associated with a strong build-up oftoxicity in associated pathways, such as e.g., generationof Reactive Oxygen Species (ROS), and a subsequent in-evitable death of a specimen. After the projecting of theexpressome δx on the leading principal component ∼ bmost information about the geometry of this “thresholdsurface” is of course lost. Nevertheless it is reasonableto assume that the death of an organism occurs oncethe projection z = (bT · δx) reaches a certain threshold,z = Z.

If the limiting toxicity occurs late in life, i.e. ifγ = αZ2/∆ � 1, the mortality grows exponentially atintermediate ages, α−1 . t . tls (where tls is the averagelifespan in the population),

M ≈ 0.61αeα(t−tls) ∼ ∆

Z2eαt, (4)

which is, essentially a form of the Gompertz law[35](see Supplementary Information, Section Bfor the de-tails of the derivation). Therefore the exponent α isdirectly related to the Mortality Rate Doubling Time(MRDT), tMRDT, by equation α = log(2)/tMRDT. Inturn, the Initial Mortality Rate (IMR), ΛIMR, is relatedto the genotoxic stress levels, ΛIMR = ∆/Z2. Normally,γ ∼ (α/ΛIMR) is large, and therefore average lifespan,E(tls) ∼ α−1 log γ � α−1, is also large compared to thecharacteristic time tα ∼ α−1 associated with the genenetwork instability. The lifespan thus depends stronglyon the morphological properties of the GRN, such as itstopology and connectivity, through the matrix K, and,more specifically, through its lowest eigenvalue ε ∼ α.The dependence of species lifespan on the genotoxic stressfactors through the parameter ∆ is, on the contrary, log-arithmically weak. This may explain why interventionsaimed at insulating a living system from stress, e.g. byregulating the environmental temperature or by decreas-ing ROS levels alone, failed to dramatically improve lifes-pan [36].

Mortality in the form similar to Eq. (4) can be asso-ciated with the gene network instability in a simple phe-nomenological model, where both IMR and MRDT wererelated to generic network parameters, such as transla-tion, gene repair and protein turnover rates, along withthe genotoxic stress levels, whereas mortality was directlyassociated with the increasing number of regulatory er-rors [17]. Therefore the expressome remodeling along theageing direction b can be related to the total unrepaireddamage accumulated over the lifespan of an organism.

As we show in Supplementary Information, the dy-namics of gene expression levels δx in a strong “Gom-pertzian” limit, γ � 1, proceeds along a well-definedtrajectory, corresponding to a continuation of the devel-opment program. This conclusion is entirely consistentwith the hyperfunction hypothesis [5] as a special case ofpre-programmed ageing. The “distance travelled” alongthe ageing direction up to a date, z ∼ (δxT ·b), is, accord-ing to Eq. (4), directly related to mortality and hence byitself is a good biomarker of mortality and ageing. Theseobservations pave the way to define a number of biologi-cal “clocks” using any number of variables characterizinga GRN state. For example, Figures 2A & C demonstratethe feasibility of a transcriptome- and metabolome- de-rived biological clock for D. melanogaster. Those clocksin turn may be compared to the biomarkers of age and thebiological age calculator (biological clock) derived from aregression model established using age-dependent DNA-methylation levels [22].

The association of GRN instability and themortality rate

Our analysis of D. melanogaster age-dependent tran-scriptional data indicates that the gene expression vari-ance grows exponentially with the age in agreement withEq. (3), with α ≈ 19.1 yr−1, as shown on Figure 2A. Ina similar fashion we have studied the composition of the“direction of ageing” b in metabolome of D. melanogaster[20] maintained on a sugar diet. The projection of themetabolome state vector onto the singular direction b in-creases very quickly with age, along with the reportedmortality as shown on Figure 2C. The average lifespanof D. melanogaster is about 25 and 40 days in both ex-periments, respectively, and in both cases the initial ex-ponetial growth of the projection z2(t) ceases at t & tls,as predicted by the theory. Figure 1B represents a sideby side comparison of the variance computed from thegene expression and the metabolomes datasets. The val-ues of instability rates, α, recovered both ways are verysimilar, and close to the value of the Gompertz expo-nent α = ln 2/tMRDT = 17.1 yr−1 corresponding to themortality rate doubling time tMRDT ≈ 0.04 yr [37].

7

Mortality rate slowdown at advanced ages

At more advanced ages, t & E(tle), where tle is theaverage lifespan in the population, solutions of Eq. (2)exhibit deceleration of mortality. More specifically, asshown in Supplementary Information, Section B 4 d, weexpect that the mortality rate ceases growing and satu-rates at a constant value, M∞ ∼ α. This quantitativeprediction can be compared with the experimental datafor medflies [21], where the cohort sizes were sufficientto observe both the regime of exponentially increasingmortality and the mortality plateau (see SupplementaryInformation, Figure 7). For the male medflies we find theasymptotic valueM∞ ≈ 0.16 day−1, which is close to theGompertz exponent α ≈ 0.22 day−1, as expected. Theasymptotic value of the mortality rate for female med-flies, M∞ ≈ 0.12 day−1, is also of the right order of mag-nitude, though nearly two times smaller than the slopeof the mortality exponent α = 0.25 day−1. Nevertheless,we emphasize the existence of a strong correlation be-tween the asymptotic value M∞ of the mortality rate atlate ages and the value of the Gompertz exponent α inboth cases and note that the approximate Eq. (4) worksbetter for longer living, or “Gompertzian”, ΛIMR � α,organisms.

Genes-biomarkers of ageing in D. melanogaster

The “direction of ageing”, vector b, is similar but notthe same as differential expression (DE) vector in ageinganimals, since the latter may include a contribution offaster modes represented by the eigenvectors of the GRNconnectivity matrix K corresponding to eigenvalues withlarger absolute value. The results of Gene Ontolology(GO) analysis of the leading components of b vector aresummarized in Figure 3A, for Biological Process (BP)categories only. A summary for Molecular Function (MF)and Cellular Compartment (CC) categories enrichmentcan be found on Supplementary Information Figures 9B& C.

The genes, providing the most significant negativecontribution to the ageing direction, b, can be roughlysplit into three groups. First, there is a large group ofgenes related to metabolic processes: organophosphatemetabolism, generation of precursor metabolites and en-ergy, membrane and mitochondria ion transport. A de-tailed review of the GO categories involved seem to in-dicate that most of the down- regulated processes arerelated to oxidative phosphorylation or respiration (seebelow). Another seemingly large group of genes involvesapparent remedies of developmental processes, such asanatomical structure formation involved in morphogen-esis and extracellular structure organization. Genes en-coding eggshell formation, more specifically, egg coat for-mation, correspond to strongly negative components ofthe vector b, which is a clear sign of the reproductivesenescence in female flies. Finally, we observe the decline

in protein folding capacity, along with an apparently re-lated “unfolded protein binding” GO MF category.

As expected, the cluster of genes corresponding to thestrongest positive components of the vector b includesgenes associated with a generic stress response. Amongother leading components are genes corresponding to hu-moral immune response (well in line with the earlierconclusions of [38]), and the components of oxidation-reduction and reactive oxygen species metabolic pro-cesses. The latter may be over-expressed with age inresponse to Reactive Oxygen Species (ROS) accumula-tion. This over-expression may be occurring on par withthe decline of the metabolic processes. The carbohy-drate metabolic processes activation may be another pro-grammed defensive measure on the background of the ox-idative phosphorylation decline (see below). This obser-vation seems to be consistent with enrichment of KEGGoxidative phosphorylation pathway by the negative lead-ers of the ageing direction, see Figure 3C.

A few transcription factors (TF) expression shifts arestrongly associated with ageing. The top positively as-sociated gene, hairy, is a transcriptional suppressor, andbelieved to be a metabolic switch, found up-regulatedin the microarrays characterizing oxygen-deprived flies.Conversely, mutations in hairy significantly reduced hy-poxia tolerance [39]. This can be either a driving forcebehind or an indication of a pre-programmed metabolicadaptation to the oxidative phosphorylation decline. Theonly negatively associated transcriptional factor, eve, isa transcriptional factor involved in multiple organ an sys-tems development.

Metabolites-biomarkers of ageing in D. melanogaster

We computed the ageing direction basing on the re-sults of the metabolic remodeling study for Drosophilamelanogaster [20]. Most of the metabolites, used in theanalysis, are not annotated (see Supplementary Informa-tion, Figure 8). To facilitate the discussion, we also re-computed the “direction of ageing” b using only the tar-geted metabolites, see Figure 2D. The results for bothtargeted and non-targeted metabolites should be takenwith a grain of salt, as metabolite level numbers for dif-ferent metabolites resulting from metabolite profiling arenot equally normalized, are not generally in one-to-onecorrespondence with metabolite concentrations in the livetissue, and thus levels of two different metabolites esti-mated by metabolite profiling strictly speaking cannotbe quantitatively compared with each other. The ef-fects of unequal normalization are especially pronouncedfor non-annotated metabolites. Nevertheless, the rela-tion between targeted metabolites turned out to be thesame in both analyses of the full metabolome and theannotated list only, which is a good indication of thestability of calculations and possibility to scale calcula-tion to state vectors with more components. The issueof unequal normalization in omics datasets can be fully

8

resolved by applying stochastic subspace identificationmethods [40], which we shall leave for a future work.

The most reliable sets of enriched metabolites par-ticipating in mitochondrial electron transport chain(alpha-glycerophosphate, succinate, NAD) mainly cor-respond to negative components in the vector b, whichis consistent with earlier reported age-associated de-cline in mitochondrial respiration and electron transportin D. melanogaster [41]. The majority of the purinemetabolism category members, such as adenosine, guano-sine, inosine, urate, glutamine, etc., are characterized bythe negative values of the vector b as well, which is con-sistent with the age-related expression decline of the geneassociated with major metabolic pathways (see above).

Human orthologs for biomarkers of ageing in D.melanogaster

According to OrthoDB, approximately 80% of all genesin D. melanogaster have human orthologs. To providemore quantitative insights into the nature of the ageingdirection, we searched for human orthologs to the leadingcontributors to the ageing direction vector b computedfrom the transcriptome of D. melanogaster. The resultsof this analysis are represented on Figures 3C & D. Afair number of the lead components of the ageing direc-tion, such as e.g. egg shell proteins, are clearly speciesdependent. At the same time the human orthologs listappears to make sense. As expected, the downregu-lated genes enrich KEGG pathways associated with ox-idative phosphorylation (consistently with the GO anno-tation and KEGG enrichment results above). On top ofthat we find the KEGG categories corresponding to theleading age-related neurodegenerative diseases (Hunting-ton’s, Parkinson’s and Alzheimer’s), and also cardiacmuscle contraction pathway. Heart failure is known tobe another common causes of death in elders. On thecontrary, KEGG PPAR signaling pathway is getting ac-tivated with age, which may be another indication ofthe aforementioned activation of anti-oxidant metabolismsystems. There is an evidence suggesting that PPARαand the genes under its control play a role in the evolu-tion of oxidative stress excesses observed in the course ofageing in mice [42].

Another characteristic piece of evidence relating thestochastic instability of the gene regulatory network withcommon age-related diseases is a strong positive contri-bution of Pepck gene, which encodes a rate-controllingenzyme of gluconeogenesis, the process by which cellssynthesize glucose from metabolic precursors. RNAi ap-proach to induce post-transcriptional gene silencing of itshuman ortholog, PEPCK, was identified as an effectiveway to sustain diabetes-induced hyperglycemia [43].

DISCUSSION

We have argued in the present paper that ageing is anorganismic level manifestation of an inherent instabilityof gene regulatory networks. Proper orthogonal decom-position of age-dependent transcriptional and metabolicprofiles shows that for Gompertzian species the life-longdynamics of the transcriptional and metabolic profilescan be effectively described as a stochastic critical dy-namics of a single degree of freedom, identified by theprojection of the expressome on the right eigenvector bof the GRN connectivity matrix K, and associated withthe eigenvalue ε vanishing at the critical point.

We established that depending on the sign of ε a GRNcan be either stable or unstable. We further invoke aform of hyperfunction theory and assume that a buildupof metabolites beyond a certain lethal level leads to deathof the organism. We note that appearance of such tox-icity thresholds is guaranteed, if non-linearities in theequation (1) for expressome levels are accounted for (seeSupplementary Information, Section B). We show thatin this limit the mortality follows a form of Gompertzlaw, i.e. first increases exponentially with age and thensaturates at a constant level, which is supported by ex-perimental evidences. As predicted, we find a strong cor-relation between the rate of gene regulatory network in-stability and the value of mortality rate saturation. Thuswe are able to demonstrate that the Gompertzian ageingis a property of organisms with inherently unstable generegulatory networks, and thus the gene network instabil-ity is a direct cause of ageing in the form of exponentialincrease of all-causes mortality with age. Since mortalityin humans, where it is characterized best, is, for most ofits part, associated with age related diseases, our calcu-lations support the idea of ageing being the driving forcebehind the development of major diseases [44].

The stochastic theory of ageing presented is fully com-patible with and, in fact, embraces the existing theoriesand hypotheses on the origin of ageing in the followingsense:

• programme of ageing [11–13]. We have shownthat ageing-driven dynamics of the expressomeδx(t) can be separated into stochastic and deter-ministic components. The deterministic compo-nent of δx(t) starts to dominate over the stochasticone already early in life, at roughly the same timewhen the low rank approximation of the GRN con-nectivity matrix K becomes valid. As the dynam-ics of the expressome δx(t) is largely determined bythe properties of the matrix K, we identify the lowrank approximation of K as a quasi-programme ofageing.

• hyperfunction theory [5, 6]. The single modeδx = z · b, describing a large cluster of genes pro-vides a dominant contribution to the process of age-ing, starts dominating the ageing dynamics soonafter the end of the developmental stage, and the

9

stochastic effects on the expressome dynamics canbe considered relatively weak [5, 6]. The samegenes, which were highly expressed close to the endof the developmental stage, become even more over-expressed at late stages of life. Therefore it is nat-ural to associate the progressing of δx(t) along theageing mode with the hyperfunction. Moreover, in-troduction of toxicity thresholds for metabolic pro-file and gene expression levels is also consistent withthe idea of hyperfunction. More evidence in favorof the interpretation comes from recent works suchas [45], where a specific transcriptional circuit isfound, which guides the rapid ageing process in C.elegans and indicate that this circuit is driven bydrift of developmental pathways rather than accu-mulation of damage.

• damage/error accumulation [1–4]. Althoughthe stochastic component of expressome δx(t) be-comes small compared to the deterministic compo-nent at late ages, its effects are strongly pronouncedat all ages. The probability distribution functionP (δx, t) to find a specimen with the expressomeδx(t) and age t in a population is never peakednear a particular value of δx. On the contrary, wehave argued in the present paper, that the meansquare deviation

√E(δx2(t)) grows with age at the

same exponential Gompertz rate as the mortalityM(t). As we will demonstrate in the future work,this growth of stochasticity in population can bedirectly associated with the effect of error accumu-lation in metabolism and gene regulation throughthe estimation of entropy growth rate, as has beenearlier suggested by [46, 47].

• antagonistic pleiotropy [9]. Since a single modeδx = z · b determines the dynamics of the expres-some δx(t) through the most of the adult life, ex-pression levels of the genes, highly expressed in theend of developmental stage, will first reach toxicitythresholds leading to statistical increase of mortal-ity. Such highly expressed genes are clearly selectedfor, as they promote the fitness of the organism inyouth. This observation is very much in the spiritof the hypothesis of antagonistic pleiotropy.

The established relation between the critical dynamics ofthe gene regulatory network state vector and the Gom-pertzian mortality characteristic to many species allowsone to consider the projection z = (bT ·δx) as a biomarkerof ageing. Due to the low value of the eigenvalue ε the di-rection b dominates a response to a generic stress. This,in fact, was already demonstrated in [48], where tran-scriptional signatures of responses to very different geno-toxic stresses were found to share a great number of geneexpression changes.

The expressions of the genes or metabolites corre-sponding to the most significant components of theageingdirection b are strongly associated with age and age re-lated diseases. Therefore ageing in the form the GRN

instability described here leads to the impairment ofthe normal functioning of the body, has characteristicbiomarkers and symptoms including signs of major agerelated diseases, and produces exponentially increasingmorbidity. Accordingly, the process of ageing itself fallsunder the definition of a disease recently used by AMAfor a common condition such as obesity [49]. We mustnote here that therapeutic or experimental interventionsaimed to counter-balance the age related changes in thegenes or metabolites expressions may not be very effec-tive ways to extend lifespan of the species. For example,even though ageing in D. melanogaster is associated withincreased internal and external bacterial load, as well aswith increase of antibacterial peptides expression, bothreducing the bacteria population with antibiotics and re-ducing the humoral antibacterial response failed to in-duce lifespan increasing effect in experiments [50]. Thetranscriptional factor hairy is overexposed with age, nev-ertheless its inhibition did not result in lifespan increaseeither [39]. This reinforces the conclusion that the mark-ers of ageing are, in general, not the same as regulatorsof ageing.

Even though most of the analysis in the manuscriptis performed for D. melanogaster, our conclusions aregeneric and should be applicable to other species. Re-alistic GRNs with different properties may not lead toGompertz law. We believe that even more intriguingpossibility may arise if the effective potential V (z) has alocal minimum with small but positive curvature. Thehigher order nonlinearities, such as cubic component ofthe effective potential, cannot be neglected anymore andin this case genetic network turns out to be metastable. Ifthe minimum of the potential V (z) is separated from theregion of large z by a sufficiently high activation barrier(see Figure 1A and Supplementary Information, SectionB 5 c), the mortality rate, determined by the probabilityof activation, is exponentially small and age-independent.This situation is consistent with the negligible senes-cence hypothesis [51]. This model feature may provide anexplanation behind the apparent lack of age-dependentphysiological changes as well as behavior of the mortalityrate observed in naked mole rat and some other speciesover a long lifespan [52]. This argument is also supportedby the analysis in [53], where the number of the genes dif-ferentially expressed with the age was compared in nakedmole rats, mice, and humans [53, 54].

MATERIALS AND METHODS

Gene annotation

We have used the open source Ontologizer [55] tool toannotate the gene set representing the leading compo-nents of the vector b of biomarkers of ageing. The vec-tor b was first computed from the gene expression vari-ance to gene ontologies using “Parent-Child-Intersection”GO enrichment analysis procedure described in [56], a

10

method, which considers genes in the background if theyare present in all parent terms of the term of interest. Forcomparison purposes we also present a standard Term-by-Term GO enrichment (BP only) analysis on Supple-mentary Information Figures 9A. We employed 0.01 ad-justed p-value cutoff (Benjamini-Hochberg multiple testcorrection). We have performed KEGG pathway enrich-ment analysis of the genes corresponding to the most sig-nificant components of vector b, computed from the tran-scriptome of D. melanogaster [19] and the correspondinghuman orthologs using DAVID web-tool [57, 58].

Metabolic enrichment analysis

To analyze the vector b, obtained from the metabolomeof D. melanogaster [20], we have performed a metabolite

set enrichment analysis for the components of vector busing MetaboAnalyst 3.0 [59]. The total number of thetargeted metabolites is too small to analyze the positivelyand negatively regulated substances separately. 80 com-ponents of the vector b with highest absolute value arerepresented on Figure 3B.

ACKNOWLEDGMENTS

The authors are grateful to Profs. A. Moskalev, V.Gladyshev and V. Fontana, Drs. A. Avanesov and M.Konovalenko for valuable discussions, Dr. U. Fischer andto S. Filonov and M. N. Kholin for enlightening com-ments, discussions and substantial help in preparation ofthe manuscript. We would also like to thank Prof. J.Carey for access to the experimental data.

[1] Partridge, L. & Gems, D. Mechanisms of ageing: publicor private? Nat. Rev. Genet. 3, 165–75 (2002). URLhttp://dx.doi.org/10.1038/nrg753.

[2] Sinclair, D. A. & Oberdoerffer, P. The ageing epigenome:damaged beyond repair? Ageing Res. Rev. 8, 189–98(2009). URL http://www.sciencedirect.com/science/article/pii/S1568163709000245.

[3] Gladyshev, V. N. On the cause of aging and control oflifespan: heterogeneity leads to inevitable damage accu-mulation, causing aging; control of damage compositionand rate of accumulation define lifespan. Bioessays 34,925–9 (2012).

[4] Gladyshev, V. N. The origin of aging: imperfectness-driven non-random damage defines the aging process andcontrol of lifespan. Trends Genet. 29, 506–12 (2013).

[5] Blagosklonny, M. V. Aging and immortality: quasi-programmed senescence and its pharmacologic inhibi-tion. Cell Cycle 5, 2087–2102 (2006).

[6] Blagosklonny, M. V. & Hall, M. N. Growth and aging: acommon molecular mechanism. Aging 1, 357 (2009).

[7] Kirkwood, T. B. L. Evolution of ageing. Nature 270,301–304 (1977).

[8] Kirkwood, T. B. & Austad, S. N. Why do we age? Nature408, 233–8 (2000).

[9] Williams, G. Pleiotropy, natural selection, and the evolu-tion of senescence. Science’s SAGE KE 2001, 13 (2001).

[10] Reis, R. J. S. Model systems for aging research: syncreticconcepts and diversity of mechanisms. Genome 31, 406–412 (1989).

[11] Skulachev, V. The programmed death phenomena, aging,and the Samurai law of biology. Exp. Gerontol. 36, 995–1024 (2001).

[12] Longo, V. D., Mitteldorf, J. & Skulachev, V. P. Pro-grammed and altruistic ageing. Nat. Rev. Genet. 6, 866–72 (2005).

[13] de Magalhães, J. a. P. Programmatic features of agingoriginating in development: aging mechanisms beyondmolecular damage? FASEB J. 26, 4821–6 (2012). URLhttp://www.fasebj.org/content/26/12/4821.short.

[14] Orgel, L. E. Ageing of Clones of Mammalian Cells. Na-ture 243, 441–445 (1973).

[15] Hopfield, J. J. Kinetic Proofreading: A New Mechanismfor Reducing Errors in Biosynthetic Processes RequiringHigh Specificity. Proc. Natl. Acad. Sci. 71, 4135–4139(1974).

[16] Danchin, A. Natural selection and immortality.Biogerontology 10, 503–16 (2009).

[17] Kogan, V., Molodtcov, I., Menshikov, L. I., Reis, R. J. S.& Fedichev, P. Stability analysis of a model gene networklinks aging, stress resistance, and negligible senescence.arXiv preprint arXiv:1408.0463 (2014).

[18] Antoulas, A. C. Approximation of Large-Scale DynamicalSystems (SIAM, 2009).

[19] Pletcher, S. D. et al. Genome-wide transcript pro-files in aging and calorically restricted< i> drosophilamelanogaster</i>. Current Biology 12, 712–723 (2002).

[20] Avanesov, A. S. et al. Age-and diet-associatedmetabolome remodeling characterizes the aging processdriven by damage accumulation. eLife 3 (2014).

[21] Vaupel, J. W. et al. Biodemographic trajectories oflongevity. Science 280, 855–860 (1998).

[22] Horvath, S. Dna methylation age of human tissues andcell types. Genome biology 14, R115 (2013).

[23] Balleza, E. et al. Critical dynamics in genetic regulatorynetworks: examples from four kingdoms. PLoS One 3,e2456 (2008).

[24] Krotov, D., Dubuis, J. O., Gregor, T. & Bialek, W.Morphogenesis at criticality. Proceedings of the NationalAcademy of Sciences 111, 3683–3688 (2014).

[25] Fiedler, B. E. Handbook of Dynamical Systems, Volume2 (Gulf Professional Publishing, 2002).

[26] Seydel, R. Practical Bifurcation and Stability Analysis,vol. 1 (Springer Science & Business Media, 2009).

[27] Suzuki, M. Passage from an initial unstable stateto a final stable state. In Advances in ChemicalPhysics, Volume 46, 195–276 (John Wiley & Sons, 2009).URL http://books.google.com/books?hl=en&lr=&id=6uAY7tkKEVkC&pgis=1.

[28] The latter observation is supported by the analysis of therecent experiments in D. melanogaster, where transcrip-tional responses to different stress factors were found tocontain a good fraction of similar differentially expressed

11

genes both in the limit of nearly lethal [60] and weakstressors [48].

[29] Morse, C. Does variability increase with age? an archivalstudy of cognitive measures. Psychol Aging 8, 156–64(1993).

[30] Rother, P. The aging changes of biological variability(author’s transl). ZFA 33, 463–6 (1978).

[31] Khalyavkin, A. & Krutko, V. Aging is a simple de-privation syndrome driven by a quasi-programmed pre-ventable and reversible drift of control system set pointsdue to inappropriate organism-environment interaction.Biochemistry (Moscow) 79, 1133–1135 (2014).

[32] Arlia-Ciommo, A., Piano, A., Leonov, A., Svistkova, V.& Titorenko, V. I. Quasi-programmed aging of bud-ding yeast: a trade-off between programmed processesof cell proliferation, differentiation, stress response, sur-vival and death defines yeast lifespan. Cell Cycle 13,3336–3349 (2014).

[33] Blagosklonny, M. V. Answering the ultimate question"what is the proximal cause of aging?". Aging 4, 861–877(2012).

[34] Blagosklonny, M. V. Mtor-driven quasi-programmed ag-ing as a disposable soma theory. Cell Cycle 12, 1842–1847 (2013).

[35] Gompertz, B. On the nature of the function expressiveof the law of human mortality, and on a new mode ofdetermining the value of life contingencies. Philosophicaltransactions of the royal society of London 115, 513–583(1825).

[36] Gems, D. & Doonan, R. Antioxidant defense and agingin c. elegans: is the oxidative damage theory of agingwrong? Cell Cycle 8, 1681–1687 (2009).

[37] Tacutu, R. et al. Human ageing genomic resources: Inte-grated databases and tools for the biology and genetics ofageing. Nucleic acids research 41, D1027–D1033 (2013).

[38] Khan, I. & Prasad, N. The aging of the immune responsein drosophila melanogaster. The Journals of GerontologySeries A: Biological Sciences and Medical Sciences 68,129–135 (2013).

[39] Zhou, D. et al. Mechanisms underlying hypoxia tolerancein drosophila melanogaster: hairy as a metabolic switch.PLoS genetics 4, e1000221 (2008).

[40] Overschee, V. & Moor, D. Subspace Identification forLinear Systems: Theory, Implementation, Applications(Kluwer Academic, 1996).

[41] Ferguson, M., Mockett, R., Shen, Y., Orr, W. & Sohal, R.Age-associated decline in mitochondrial respiration andelectron transport in drosophila melanogaster. Biochem.J 390, 501–511 (2005).

[42] Poynter, M. E. & Daynes, R. A. Peroxisome proliferator-activated receptor α activation modulates cellular redoxstatus, represses nuclear factor-κb signaling, and reducesinflammatory cytokine production in aging. Journal ofBiological Chemistry 273, 32833–32841 (1998).

[43] Gómez-Valadés, A. G. et al. Overcoming diabetes-induced hyperglycemia through inhibition of hepaticphosphoenolpyruvate carboxykinase (gtp) with rnai.Molecular Therapy 13, 401–410 (2006).

[44] Blagosklonny, M. V. Validation of anti-aging drugs bytreating age-related diseases. Aging 1, 281 (2009).

[45] Budovskaya, Y. V. et al. An< i> elt-3/elt-5/elt-6</i>gata transcription circuit guides aging in< i> c. ele-gans</i>. Cell 134, 291–303 (2008).

[46] Hayflick, L. Entropy explains aging, genetic determinismexplains longevity, and undefined terminology explainsmisunderstanding both. PLoS Genet. 3, e220 (2007).

[47] Christensen, K., Doblhammer, G., Rau, R. &Vaupel, J. W. Ageing populations: the chal-lenges ahead. Lancet 374, 1196–208 (2009). URLhttp://www.sciencedirect.com/science/article/pii/S0140673609614604.

[48] Moskalev, A. et al. Mining gene expression datafor pollutants (dioxin, toluene, formaldehyde) and lowdose of gamma-irradiation. PLoS ONE 9, e86051(2014). URL http://dx.doi.org/10.1371%2Fjournal.pone.0086051.

[49] American medical association, resolution 420 (a-13):recognition of obesity as a disease. In Proceedings of theHouse of Delegates 162nd Annual Meeting (2013).

[50] Ren, C., Webster, P., Finkel, S. E. & Tower, J. In-creased internal and external bacterial load during< i>drosophila</i> aging without life-span trade-off. Cellmetabolism 6, 144–152 (2007).

[51] Finch, C. E. Longevity, senescence, and the genome (Uni-versity of Chicago Press, 1994).

[52] Buffenstein, R. The naked mole-rat: a new long-livingmodel for human aging research. The Journals of Geron-tology Series A: Biological Sciences and Medical Sciences60, 1369–1377 (2005).

[53] Kim, E. B. et al. Genome sequencing reveals insights intophysiology and longevity of the naked mole rat. Nature479, 223–227 (2011).

[54] Jeannette Loram, A. B. Age-related changes in gene ex-pression in tissues of the sea urchin< i> strongylocentro-tus franciscanus</i>. Mechanisms of Ageing and Devel-opment 133, 338–347 (2012).

[55] Bauer, S., Gagneur, J. & Robinson, P. N. Going bayesian:model-based gene set analysis of genome-scale data. Nu-cleic acids research 38, 3523–3532 (2010).

[56] Grossmann, S., Bauer, S., Robinson, P. N. & Vingron,M. Improved detection of overrepresentation of gene-ontology annotations with parent–child analysis. Bioin-formatics 23, 3024–3031 (2007).

[57] Da Wei Huang, B. T. S. & Lempicki, R. A. System-atic and integrative analysis of large gene lists usingdavid bioinformatics resources. Nature protocols 4, 44–57(2008).

[58] Huang, D. W., Sherman, B. T. & Lempicki, R. A. Bioin-formatics enrichment tools: paths toward the compre-hensive functional analysis of large gene lists. Nucleicacids research 37, 1–13 (2009).

[59] Xia, J., Mandal, R., Sinelnikov, I. V., Broadhurst, D. &Wishart, D. S. Metaboanalyst 2.0-a comprehensive serverfor metabolomic data analysis. Nucleic acids research 40,W127–W133 (2012).

[60] Brown, J. B. et al. Diversity and dynamics of thedrosophila transcriptome. Nature (2014).

[61] Kadish, I. et al. Hippocampal and cognitive aging acrossthe lifespan: a bioenergetic shift precedes and increasedcholesterol trafficking parallels memory impairment. TheJournal of Neuroscience 29, 1805–1816 (2009).

[62] The number of different principal components PCn rep-resenting the signal x(t1), . . . , x(tm) does not exceed m.

[63] Schervish, M. J. Theory of Statistics, vol. 21 (SpringerNew York, 2011).

[64] In particular, the rate of these changes is limited by asingle gene transcription time, ∼ 1 min.

12

[65] In particular, they are not small at early times, close tothe initial state of the expressome.

[66] When higher order derivatives in Eq. (A1) are takeninto account, this argument, albeit becoming more in-volved, remains valid: one has to construct the pertur-bation theory in powers of small parameter ε, whichstill determines the smallest eigenvalue of the matrixA(f) = K + i2πfD + (2πf)2M + . . . . Similarly to thecase considered here, all higher eigenvalues of A(f) pos-sess positive real parts.

[67] Zwanzig, R. Nonequilibrium Statistical Mechanics (Ox-ford University Press, USA, 2001).

[68] Of course, albeit natural, this is still an assumption, asdifferent gene expressions are not truly independent GRNstate variables.

[69] Suzuki, M. Scaling theory of transient phenomena nearthe instability point. Journal of Statistical Physics 16,11–32 (1977). URL http://link.springer.com/10.1007/BF01014603.

[70] Redner, S. A Guide to First-Passage Processes (Cam-bridge University Press, 2001).

[71] Aalen, O., Borgan, O. & Gjessing, H. Survival and EventHistory Analysis: A Process Point of View (Springer,2008).

[72] Weitz, J. S. & Fraser, H. B. Explaining mortality rateplateaus. Proc. Natl. Acad. Sci. U. S. A. 98, 15383–6(2001).

[73] Steinsaltz, D. & Evans, S. N. Markov mortality mod-els: implications of quasistationarity and varying initialdistributions. Theor. Popul. Biol. 65, 319–37 (2004).

13

SUPPLEMENTARY INFORMATION

Appendix A: Stochastic dynamics of gene expressionand metabolic levels

In the following, we explain the physical basis for Eq.(2) and provide its derivation. We also explicitly findthe expressions for the mortality rate, the survival prob-ability, the lifespan distribution function and the averagelifespan of species with expressome subject to Eq. (2).

1. Getting a grasp on the dynamics of expressome.Model reduction and physical considerations

The analysis represented in this paper is mainly basedon the observation that time series datasets describingchanges of expressome profiles with age are often wellsusceptible to Model Reduction techniques [18]. One ofsuch methods often used in Big Data analysis is properorthogonal decomposition (POC).

Applying POC to age-associated transcriptional andmetabolic profile dynamics datasets (for example, [19,20, 61]) shows that the long-time behavior of the ex-pressome x is largely determined by a single principalcomponent (see Fig. 4). Although the number of timesnapshot points in corresponding time series is typicallylimited,[62] clear dominance of PC1 in the signal is a non-trivial fact. As we argue here, it carries an important in-formation about biological gene regulatory and metabolicnetworks; namely, it shows that such networks are pre-critical in the sense, which will be explained below.

Consider a meta-stable gene regulatory network(GRN) with the instantaneous network state representedby a vector x, whose components xi are given by ex-pression levels of different genes, proteins or metabolitesparticipating in the GRN.

Dynamics of the vector x is affected by mRNA levels,concentrations of proteins and metabolites, involved inregulatory pathways and in are in turn influenced by ex-ternal as well as endogenous stress factors acting on thecell. This dynamics is governed by differential matrixequations of systems biology

g

(x,dx

dt,d2x

dt2, . . .

)= F, (A1)

where g is a vector function of the state vector x, en-coding interactions between different components of theexpressome, where the notations and variables are intro-duced in the main text of the paper.

Generally, the vector function g may depend on arbi-trarily high time derivatives dx

dt ,d2xdt2 , . . . ,

dnxdtn , . . . of the

expressome state vector. Hereinafter the focus is on thestudy of dynamics of x at time scales comparable to themortality rate doubling time tMRDT, which is of the or-der of tens of days for nematodes and drosophilae, and is

1 2 3 4 50

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

i, # of singular value

Si(x

(t))

/S1(x

(t))

D. melanogaster, transcriptome

R. norvegicus, hyppocamp., transcriptome

D. melanogaster, metabolome (annotated)

D. melanogaster, metabolome (full)

Figure 4: Five largest singular values Si(x(t)) of theexpressome x(t) divided by the largest one, S1(t);transcriptome of D. melanogaster [19] (blue),

transcriptome of R. norvegicus, hippocampus [61](green), metabolome of D. melanogaster, targetedmetabolites only [20] (red), metabolome of D.

melanogaster, all metabolites [20] (purple). One of theprincipal components of the expressome x(t) clearlydominates over the others in all considered cases.

even larger, hundreds of days, for mice. This time scaleis to be compared to a typical time scale of protein trans-lation and regulation, or a life time of mRNA, encodedin the dynamics of the vector F . In order to describe thisslow dynamics of the expressome state vector x, one canneglect all time derivatives of x higher the first derivativedxdt . The matrix Eq. (A1) thus reduces to

g

(x,dx

dt

)= F. (A2)

2. Frequency domain properties of the vector F ofstress factors

As was explained above, the vector F of environmentaland endogeneous stress factors affecting gene expressionlevels x has both slowly changing component, F0(t), andstochastic component, δF (t), rapidly changing in time.Below we assume for simplicity that F0(t) = F0, i.e.,slowly changing component is in fact constant.

Since dynamics of the vector δF can be considered es-sentially random at time scales of interest for us, dynam-ics of x is driven by correlation properties of δF . Thetotal number of environmental and internal stress fac-tors affecting gene expression levels x is extremely large,and the vector δF (t) represents a superposition of thesefactors. According to the central limit theorem [63] itcan thus be considered a Gaussian stochastic process, sothat

E(δF (t)δF (t′)) = B(t− t′),

14

where B(t− t′) is a function of the time difference |t− t′|only, while E(. . .) as usual denotes the expectation valueof the fluctuating quantity . . ., and statistical averageis understood as average over ensemble of species/cellsof a given organism. In the frequency domain, one hascorrespondingly

E(δF (f)δF (−f)) =

=

ˆdf e−2πif(t−t′)E(δF (t)δF (t′)) = B(f),

where f is frequency of a given mode in the Fourier ex-pansion of the function B(t− t′).

The function B(f) has multiple singularities in thecomplex plane of f . These singularities encode charac-teristic time scales of pathways’ dynamics. However, thetwo following observations are important for the subse-quent analysis. First of all, the function B(f) decaysquickly with f as f → ∞. This guarantees that theamount of stress affecting the gene expression levels xdoes not change very rapidly.[64] On the other hand, thebehavior of B(f) is smooth at very small frequencies,i.e., B(f) → B as f → 0, so that the amplitude of rarefluctuations of δF remains limited. As we would like tounderstand the dynamics of x at time scales comparableto tMRDT, we consider the case B(f) ∼ B in what fol-lows. In this, the stochastic process δF (t) in the r.h.s. ofEq. (A2) has correlation properties of white noise:

E(δF (t)δF (t′)) = Bδ(t− t′), (A3)

where δ(t− t′) is the Dirac delta-function.

3. In the vicinity of a stationary point(homeostasis)

When the genotoxic forces are relatively weak, |δF | �|F0|, the fluctuations of the expressome state vector arealso small: x = x0 + δx, δx� x0. Here x0 is the station-ary point given by the solution of the equation

g(x0) = F0.

In the vicinity of this point Eq. (A2) reduces to

Dδx+Kδx+ Γ(3)δxδx+ . . . = δF, (A4)

where the matrices D and K describe the relaxation ef-fects and the “interaction” between genes in the GRN.The matrix Γ(3) encodes the leading non-linear termsin the expansion of the vector function g(x) in pow-ers of small δx, while . . . denote higher order terms inthis expansion. Generally, such non-linear terms are notsmall[65] However, a common feature of the dissipativenetwork described by Eq. (A4) is the decay of (most)principal components of δx with time, which makes non-linearities in Eq. (A4) less relevant at later stages of thetime dynamics. Whether this feature holds for the GRNunder consideration is a non-trivial question, which weshall now address.

4. Saddle-node bifurcation and criticalslowing-down

Domination of a single principle component in the ex-pressome vector x(t) is not a generic prediction of themodel (A4). We would like to argue that such a domi-nance implies that GRNs under consideration are oper-ating at the critical point. This critical point is a bifurca-tion, separating regimes of stable and unstable run-awaybehavior of the expressome δx.

Transition from stability to instability in networks withnetwork graphs not possessing specific symmetries is typ-ically associated with existence of co-dimension 1 bifur-cations [25, 26]. Such transition is characterized by theloss of stability along a single principal component of thenetwork state vector. Contributions from all other prin-cipal components remain stable. This situation is knownin the literature as saddle-node bifurcation [25] and isrealized, when the lowest (real) eigenvalue of the matrixK reaches zero and then becomes negative.

Let us denote the smallest (vanishing, but positive)eigenvalue of the matrix K as ε and its correspondingleft and right eigenvectors - as a and b. In order to un-derstand dynamics of the expressome δx near the GRNbifurcation, it is convenient to analyze the autocorrela-tion function E(δx(t)δx(t′)). The latter is given by thefollowing expression (in the frequency domain)

E(δx(t)δxT (t′)) =

=

ˆdf ·e−2πif(t−t′)A−1(f)E(δF (−f)δFT (f))A∗,−1(f),

(A5)where A(f) = i2πDf + K. Its behavior is determinedby the poles of the integrand in the complex plane offrequency f . In turn, the latter are given by the solutionof the equation

det(A(f)) = 0,

i.e., by the solution of the eigenvalue problem for thematrix ±i(2π)−1D−1K. In particular, at very large timeseparations |t− t′| one finds that

E(δx(t)δxT (t′)) ≈ (aT ·Ba)b · bT

ε(aT ·Db)3exp

(− ε|t− t′|

(aT ·Db)

).

(A6)Several important observations can be made at this point:(1) as the parameter ε approaches 0, amplitude of the au-tocorrelation function (A6) grows as ε−1, i.e., fluctuationsof the expressome vector are strongly amplified both withage and among the population (the statistical ensemble);(2) the autocorrelation time scale τ = (aT · Db)/ε alsogrows strongly at ε→ 0, implying that stochastic dynam-ics of the expressome becomes very slow near the point ofbifurcation, phenomenon known as critical slowing-down(see for example [27]); (3) fluctuations of the expressomevector δx mostly develop along the direction b of the

15

right eigenvector of K corresponding to the vanishingeigenvalue ε, this in turn guarantees that a single prin-cipal component of the expressome vector δx dominates;(4) the corresponding left eigenvector a determines direc-tions of high sensitivity of the expressome to genotoxicstress factors δF .

As the behavior (A6) of the autocorrelation functionis dominated by the lowest eigenvalue of the matrix−i(2π)−1D−1K (proportional in turn to the lowest eigen-value ε of the matrix K), other remaining eigenvaluesof −i(2π)−1D−1K have strictly positive real parts andthus correspond to contributions to (A6), rapidly decay-ing with time. This guarantees that only one principalcomponent of δx dominates, in accordance with experi-mental observations.[66]

When ε crosses 0 and becomes negative, the autocor-relation function (A6) develops unstable behavior, againdirected along the corresponding right eigenvector b ofK. In particular, one finds for the dispersion of the ex-pressome at large t

E(δx(t)δxT (t)) ≈ E(z2(0))b · bT exp

(2εt

(aT ·Db)

),

(A7)where E(z2(0)) is the dispersion of the projection z =(δxT · b) of the expressome on the vector b, taken at theinitial moment of time. Dynamics of the expressome δxalong other principal components remains stable.

Thus, the quantity of interest in the critical regimeε→ 0 is the projection of the expressome δx on the righteigenvector b:

z = (δxT · b),

which satisfies the Langevin equation

dz

dt= αz+βz2 + . . .+f, E(f(t)f(t′)) = ∆δ(t− t′) (A8)

where α = ε/(aT · Db), β = (aT · Γ(3)bb)/(aT · Db), . . .and ∆ = (aT ·Ba)/(aT ·Db)3.

This concludes the derivation of Eq. (2).

Appendix B: Estimating mortality rates from thestochastic dynamics of expressome

So far we have only considered stochastic dynamics ofthe expressome state vector δx of an organism. To pro-ceed with population properties, such as mortality, weneed to construct a statistical description for populations,ensembles of organisms. Consider a large population ofanimals with the number of species N(t = 0) = N0 � 1,born at the same moment of time, t = 0. The develop-ment and ageing of animals in the population dependson the dynamics of the expression levels x and can benaturally described in terms of the probability densitydN = P (x, t) dx, where P (x, t) is the fraction of of spec-imen within the population with the gene expression lev-els within the interval (x− dx, x+ dx) estimated at time

t. Another quantity of interest is the survival probabilityS(t), defined as the ratio of the number of species N(t)still alive at time t to their initial number N0. The asso-ciated mortality rate can then be found using the expres-sionM(t) = −dSdt /S. In this Section we shall explain howto estimate both the probability density P (z, t), the sur-vival probability S(t) and the mortality rate M(t) fromthe stochastic dynamics of the expressome state vectorδx.

1. Estimating the probability density P (z, t)

As was discussed above, the process of ageing is charac-terized by slow changes in gene expression levels δx overtime, described by the Langevin equation (A8). Here-inafter in this Section for the sake of briefness we dropδ in δz, denoting the fluctuation of the expressome δzsimply as z. The probability P (z, t) is the solution of theassociated Fokker-Planck equation [67]

∂P (z, t)

∂t=

∂

∂z

((αz + βz2 + γz3 + . . .)P (z, t)

)+

+1

2∆∂2P (z, t)

∂z2, (B1)

subject to the initial condition P (z, t = 0) = P0(z) anda boundary condition at large z. In what follows weconsider two particular cases: a “deterministic” initialcondition

P (z, t = 0) = δ(z), (B2)

where z is the Dirac delta-function, and the Gaussianinitial condition

P (z, t = 0) =1√

2πδz20

e− (z−z0)2

2δz20 . (B3)

A physically relevant choice of the boundary condition atlarge z is

P (z →∞, t) = 0, (B4)

implying that all specimen with sufficiently large z asso-ciated with high toxicity will necesserily die and drop outfrom the distribution. Our reasoning behind the choiceof this particular boundary condition is as follows. Letus assume that for every gene in the genome there ex-ists a particular threshold Xi of its expression, which isassociated with a strong build-up of toxicity in associ-ated pathways and a subsequent inevitable death of aspecimen.[68] After the projection on the leading prin-cipal component ∼ b of the expressome δx most infor-mation about the geometry of this “threshold surface” isof course lost. However, one notes that the character-istic time for the stochastic process z(t) to reach infin-ity z = ∞ is always finite, as long as non-linear terms

16

are present in the Fokker-Planck equation (B1), and thestate z =∞ is certainly associated with the death of thespecimen. Thus, expressions for the average lifespan andthe survival probability derived below are at least goodupper bounds on the real average lifespan and survivalprobability of the species in question.

The choice of the boundary condition (B4) is especiallysuitable in the case, when non-linearities in Eq. (A8) aretaken into account, i.e., at least some of β, γ, . . . in Eq.(B1) are non-zero.

In the case, when only α 6= 0 the appropriate counter-part of the boundary condition (B4) is

P (z = Z, t) = 0, (B5)

meaning that specimen die, when z reaches a certainthreshold value Z. The boundary conditions (B4) and(B5) are associated in the following sense. If β 6= 0,while all other non-linearities in Eq. (A8) are absent,all the expressions for the probability distribution func-tions and correlation functions of the expressome remainthe same as in the linear case, but with a substitutionZ ∼ (α/β)1/2. A similar conclusion (but with a slightlydifferent expression for Z) holds, when the next ordernon-linearity γ is taken into account, see below. Thus,the cases (B4) and (B5) are essentially physically equiv-alent, and one can switch between the discussion of non-linear Fokker-Planck equation (B1) and the linear one,whenever convenient.

The Fokker-Planck equation (B1) with the boundaryconditions (B4) or (B5) cannot be solved exactly. How-ever, this is not really needed: a large amount of usefulinformation about stochastic dynamics of the expressomecan be extracted from the asymptotic behavior of theprobability density P (z, t) in various physically interest-ing regimes [27, 69].

In particular, at sufficiently early times t � α−1 be-havior of δz described by the Langevin equation (A8) isentirely dominated by the effect of the random force f(t),dominating over the “deterministic” force −αz [27, 69].One immediately finds for the case of Gaussian initialdistribution (B3):

P (z, t) ≈ 1√2πE(δz2(t))

e− (z−E(z(t)))2

2E(δz2(t)) , (B6)

where E(z(t)) = z0 exp(αt) and

E(δz2(t)) = δz20 +

(δz2

0 +∆

α

)(exp(2αt)− 1). (B7)

Therefore, in the average both expressome and its fluc-tuations grow exponentially with time. This conclusionis confirmed by the data analysis of senescence-associatedtranscriptional dynamics. It is worth emphasizing thatthe characteristic time scale of the stochastic growth ofthe expressome is ∼ α−1. It thus depends only on themorphological properties of the GRN and does not de-pend on the genotoxic stress amplitude ∆ at all.

The “intermediate” regime realized at α−1 < t .

α−1 log(α1/2Z∆1/2

), when the deterministic force αz dom-

inates over the random force f(t) in the Langevin equa-tion (A8), is characterized by so called Suzuki scaling[27, 69]. In this regime, the Fokker-Planck equation (B1)effectively reduces to a deterministic drift equation

∂P (z, t)

∂t=

∂

∂z

((αz + βz2 + γz3 + . . .)P (z, t)

).

Its solution is

P (z, τ) =h′(z)

(2πτ)1/2exp

(−h

2(z)

2τ

), (B8)

where τ = exp(2αt) is the Suzuki time variable, and thefunction h(z) has to be found on the case-by-case ba-sis by matching the solution (B8) to the solution of theFokker-Planck equation at early times (for example, toEq. (B6)). We would like to again emphasize that the ex-pression (B8) holds for both linear and non-linear cases,although the form of the function h(z) will be differentfor them. The regime of Suzuki scaling will be discussedin more details in the next Subsection.

Finally, no general statement can be made regardingthe behavior of P (z, t) at large t � α−1 log

(α1/2Z∆1/2

). If

the function V (z) = −´ zdz′(αz + βz2 + γz3 + . . .) has

not only a maximum at z = 0, but also a true minimumat some large z = zequilib, the probability density P (z, t)approaches a normalizable time-independent asymptotics

P (z) ∼ exp

(−V

′′(zequilib)(z − zequilib)2

∆

).

On the other hand, if no true minima of the function V (z)exist, the non-normalizable probability density P (z, t)exponentially quickly vanishes at t → +∞ (also see be-low). This choice seems to be a physically appropriateone, since at very high (toxic) values z GRNs simply dis-sociate, and the whole description of the system state interms of the leading principal component of δz no longermakes sense.

2. Estimating the first passage time and survivalprobabilities

In the case under consideration, a more relevant quan-tity to calculate and analyze is not the probability densityP (z, t) itself, but a so called first passage time distribu-tion function PFPT(t) [70, 71]. The reason is that theprobability density P (z, t) represents a sum over all pos-sible stochastic trajectories z(t), including those, whichpass the threshold z = Z and then return back. On theother hand, by definition, PFPT(T ) is a probability for agiven stochastic trajectory z = z(t) to pass the thresh-old z = Z at t = T for the very first time. As such, itdoes not take into account trajectories, which then returnback into the allowed domain of z.

17

5 10 150

0.2

0.4

0.6

0.8

1

2α t

P

FPT(t)/2α

S(t)

Figure 5: The first passage time distribution functionPFPT(t) (in units of 2α) and the survival probability

S(t) as a function of time 2αt; αZ2

∆ = 1000.

When a deterministic initial condition (B2) is chosen,the first passage time distribution function is given by

PFPT(t) ≈ 2αZ · e2αt

(e2αt − 1)3/2

( α

2π∆

)1/2

exp

(− αZ2

2∆(e2αt − 1)

),

(B9)while for the Gaussian initial condition (B3) one finds

PFPT(t) ≈ 2Z∆ · e2αt

√2π(δz2

0 +(δz2

0 + ∆α

)(e2αt − 1)

)3/2×

× exp

(− Z2

2(δz2

0 +(δz2

0 + ∆α

)(e2αt − 1)

)) . (B10)

In the regime of Suzuki scaling α−1 < t .

α−1 log(α1/2Z∆1/2

)the expression (B9) reduces to

PFPT(t) ≈ 2αZ( α

2π∆

)1/2

exp

(−αt− αZ2

2∆e−2αt

),

(B11)well known in literature. The function (B11) grows expo-nentially at small t . α−1, possesses a distinct maximum

at tmax = E(tls) = α−1 log

((αZ2

∆

)1/2), with its width

δt ∼ α−1 near the maximum and finally decays as e−αtat t� tmax,see Fig. 5.

Computing the first passage time distribution functionalso allows one to easily estimate the survival probability

S(t), using the prescription PFPT (t) = −dS(t)dt . From Eq.

(B11) we immediately find

S(t) ≈ Erf

((αZ2

2∆

)1/2

e−αt

), (B12)

expression precise up to terms, exponentially small atαZ2

∆ � 1, i.e., when a species is considered long-livedcompared to the characteristic time scales of moleculardynamics in the cell, see the next Subsection. The func-tion (B12), initially exponentially close to 1, then falls offquickly (as we shall see below, this fall-off corresponds toan exponentially growing mortality rate) and finally ap-proaches zero as exp(−αt) at t� α−1 log

(α1/2Z∆1/2

).

3. Average lifespan

Although it is impossible to find an exact solutionfor the first passage time distribution function and thesurvival probability in a generic non-linear case withβ, γ, . . . 6= 0 (expressions found in the previous Subsec-tion are only generally valid in the regime of Suzuki scal-ing), it is possible to find a closed form expression for theaverage lifespan E(tls) within the population as well asarbitrarily high moments E(tnls) of the lifespan. Here weshall present the final result for E(tls) without derivation:

E(tls) =1

∆

ˆ +∞

z0

dz · exp(−2v(z))

ˆ +∞

z

dz′ exp(2v(z′)),

where v(z) = V (z)∆ = − 1

∆

(12αz

2 + 13βz

3 + . . .). In par-

ticular, for the case α, β 6= 0, γ = 0, . . . one immediatelyfinds

E(tls) ≈1

αlog

(α

β1/2∆1/2

)(B13)

at large αβ1/2∆1/2 � 1 . Similarly, in the case α 6= 0, β =

0, γ 6= 0, . . . one finds

E(tls) ≈1

αlog

(α2

γ∆2

),

etc. One again sees that non-linear cases are equal tothe linear one with the appropriately chosen thresholdvalue Z (for instance, Z = (α/β)1/2 in the case β 6= 0,Zeff = α3/2/(γ∆3/2) in the case β = 0, γ 6= 0, etc.).

It is interesting to note that the average lifespan de-pends strongly on the morphological properties (topol-ogy, connectivity) of the GRN through the dependenceon α−1, while the characteristic amount of stress (its am-plitude given by ∆) affects the value of E(tls) only loga-rithmically weakly.

18

4. Behavior of the mortality rate

As usual, the mortality rate is defined following theprescription M(t) = −dSdt /S, so that one has precisely

M(t) =PFPT(t)

S(t). (B14)

We shall now focus on the particular case of the deter-ministic initial condition (B2).

a. Vanishing mortality at very early ages t� α−1

At very early ages t� α−1 the first passage time dis-tribution function is exponentially strongly suppressed:

PFPT(t) ≈ 2αZ

(2αt)3/2

( α

2π∆

)1/2

exp

(− Z2

4∆t

). (B15)

In this regime the survival probability S(t) remains ex-ponentially close to 1:

S(t) ≈ 1− 2√π

(4∆t

Z2

)2

exp

(− Z2

4∆t

).

Therefore, the mortality rate remains exponentially closeto 0, and one approximately has M(t) ≈ PFPT(t). Fromour opinion, this behavior might explain relatively smallmortality, often observed in cohorts at very early ages.We note that the behavior of the mortality rate in thisregime is not universal as it strongly depends on the am-plitude ∆ of stochastic genotoxic stress.

b. Gompertz behavior at later ages 0.54α−1 < t . α−1

As was explained above, the effect of the stochas-tic force δF in Eq. (A4) quickly becomes negligiblewith age in comparison to the effect of the “determin-istic” force −Kδx; one can easily find from the ex-pression (B7) that the two effects become comparableat times t0 ≈ α−1 log(

√3) ≈ 0.54α−1, and the “de-

terministic” force then always dominates at later timest > t0 [27, 69]. Correspondingly, the behavior (B15)quickly changes at later times t0 < t . α−1, leading tothe Gompertz-like dependence of the mortality rate onage. For the mean square deviation E(δz2) one findsE(δz2(t0)) = δz2

0 ≈ ∆α (exp(2αt0)−1) at the time t0, and

thus E(δz2(t)) ≈ δz20 + 2(δz2

0 + ∆/α)(e2α(t−t0) − 1

)at

later times t0 < t . α−1. As the survival probability isstill very close to 1, and the mortality rate is completelydetermined by the behavior of the first passage time dis-tribution function, one finds the following expression forthe logarithm of the mortality rate

logM(t) ≈ − Z2

4∆t0+log 2Z∆+2αt0+

(Z2(2αt0 + 1)

2t0+ 2α

)(t−t0).

(B16)

The value of the Gompertz exponent is thus equal to

Z2(2αt0 + 1)

2t0+ 2α ≈ Z2

2t0≈ αZ2 =

α2

β.

This expression is manifestly universal, as it depends onmorphological properties of the GRN only through theparameters α and β characterizing GRN.

c. Universal Gompertz behavior in the regime of Suzukiscaling

At even later times of the order t ∼ E(tls), when theregime of Suzuki scaling is realized, we also find a uni-versal Gompertz behavior. As was explained above, thefirst passage time probability distribution PFPT reachesa maximum at tmax = α−1 log Λ = E(tls), where Λ =α1/2Z∆1/2 , and its half-width near the the maximum is of theorder α−1, see Fig. 5. By the time t ∼ tmax the argumentof the error function in Eq. (B12) is already sufficientlysmall for it to be expanded. One thus has

S(t) ≈ 2√π

Λe−αt − 2

3√π

Λ3 exp(−3αt) + . . . .

One the other hand, one finds for PFPT(t) in the sameregime

PFPT(t) =2αΛ√πe−Λ2 exp(−2αt)e−αt,

so that approximately

M(t) ≈ αe−Λ2 exp(−2αt).

Introducing t = tmax + δt one finally finds at small δt .(2α)−1

M(t) ≈ e−1/2αeαδt ≈ 0.61αeαδt. (B17)

Thus, the Gompertz law with the universal exponentα−1 is realized at times tmax − (2α)−1 . t . tmax +(2α)−1. We again emphasize that the Gompertz ratedepends only on the properties of the GRN under con-sideration and does not depend on stress. The transitionbetween the regimes (B16) and (B17) is smooth.

d. Slowing-down of mortality at late ages

Finally, at t� tmax both the first passage time distir-bution function (B11) and the survival probability (B12)decay exponentially. This corresponds to an asymptoti-cally constant behavior of the mortality rate

M(t) ≈ α− α2Z2

2∆e−2αt − . . . , (B18)

see Fig. 6. For late t corrections to the leading constantterm become exponentially small with time. The exis-tence of mortality plateau in models of the type (A4) isknown in literature [72, 73].

19

5 10 150

0.2

0.4

0.6

0.8

1

2α t

M(t

)/α

Figure 6: The mortality rate M(t) for the case of thedeterministic initial conditions (B2); αZ

2

∆ = 1000. Themaximum of PFPT(t) is reached at 2αt ≈ 6.9.

10 20 30 40 5010

−3

10−2

10−1

100

t,days

M(t

), 1

/days

males

females

Figure 7: The mortality rate as a function of age fromthe very large cohorts study, medflies, males and

females from [21].

5. Phenomenology of the different regimes ofageing

a. The case αZ2

∆� 1

This case includes the one with a very weak non-linearity in the Fokker-Planck equation (B1) and Z2 ∼α/β and corresponds to a very high toxicity threshold Zas compared to the characteristic amplitude of fluctua-tions of the stress factors ∆. As was explained above, wenaively expect a species with such a GRN to be relativelylong-lived, as the average life expectancy (B13) is loga-rithmically larger than the inverse Gompertz exponentα−1. Four very distinct regimes of mortality exist forsuch species: (a) the regime of small mortality at earlyages, (b) a Gompertz regime with the Gompertz expo-nent ∼ α2

β � α, (b) a Gompertz regime with a universalGompertz exponent α and finally (c) a regime of con-stant mortality M∞ ∼ α. On the other hand, if indeedZ �

√δz2

0 , the initial Gompertz exponent is very large,and an arbitrary not too strongly sized population sim-ply dies out before the regime of mortality slowing-downis observed. The observed value of the average lifespan insuch populations is lower than the estimate (B13). How-ever, it strongly depends on the size of the population;increasing this size would lead to an apparent extension ofthe observed average lifespan and eventually — to the ob-servation of the regime of mortality slowing-down. Thisis perhaps what we observe in very large cohorts of Homosapiens. Note that (a) the observed value of the Gom-pertz exponent ∼ α2/β is much larger than the mortalityM∞ at late ages, (b) the value of the Gompertz exponentis relatively insensitive to the amplitude ∆ of genotoxicstress, since it only depends on the morphological prop-erties of the GRN of a species.

b. The case αZ2

∆& 1

There are again four distinct regimes (a), (b), (c) and(d) of ageing discussed above, with that difference thatthe regime (b) is a Gompertz regime with the exponent∼ α. Clearly, the regimes (b) and (c) are very close toeach other, and there is a strong correlation between theobserved value of the Gompertz exponent and the mor-tality rateM∞ at late ages. This, as it seems, is what weobserve in D. melanogaster, see Fig. 2A&C of the maintext of the paper. A relatively short average lifespan ofsuch species is comparable to the value of Gompertz ex-ponent.

c. The case α < 0, β > 0

In this case, arguably the most tempting to consider,the effective potential V (z) of the Langevin equation pos-sesses a false minimum, separated from the roll-down to

20

z → ∞ by a potential barrier, see Fig. 1d of the maintext. There exists a single regime of ageing realized forthe GRN of this type. It is characterized by a constantmortality rateM∞, its value being determined by the ex-ponentially small Kramers probability of passage through

the barrier. If a GRN with such properties indeed existsin nature, it would correspond to a species with negligiblesenescence. We leave the in-depth study of this regimefor a future work.

[1] Partridge, L. & Gems, D. Mechanisms of ageing: publicor private? Nat. Rev. Genet. 3, 165–75 (2002). URLhttp://dx.doi.org/10.1038/nrg753.

[2] Sinclair, D. A. & Oberdoerffer, P. The ageing epigenome:damaged beyond repair? Ageing Res. Rev. 8, 189–98(2009). URL http://www.sciencedirect.com/science/article/pii/S1568163709000245.

[3] Gladyshev, V. N. On the cause of aging and control oflifespan: heterogeneity leads to inevitable damage accu-mulation, causing aging; control of damage compositionand rate of accumulation define lifespan. Bioessays 34,925–9 (2012).

[4] Gladyshev, V. N. The origin of aging: imperfectness-driven non-random damage defines the aging process andcontrol of lifespan. Trends Genet. 29, 506–12 (2013).

[5] Blagosklonny, M. V. Aging and immortality: quasi-programmed senescence and its pharmacologic inhibi-tion. Cell Cycle 5, 2087–2102 (2006).

[6] Blagosklonny, M. V. & Hall, M. N. Growth and aging: acommon molecular mechanism. Aging 1, 357 (2009).

[7] Kirkwood, T. B. L. Evolution of ageing. Nature 270,301–304 (1977).

[8] Kirkwood, T. B. & Austad, S. N. Why do we age? Nature408, 233–8 (2000).

[9] Williams, G. Pleiotropy, natural selection, and the evolu-tion of senescence. Science’s SAGE KE 2001, 13 (2001).

[10] Reis, R. J. S. Model systems for aging research: syncreticconcepts and diversity of mechanisms. Genome 31, 406–412 (1989).

[11] Skulachev, V. The programmed death phenomena, aging,and the Samurai law of biology. Exp. Gerontol. 36, 995–1024 (2001).

[12] Longo, V. D., Mitteldorf, J. & Skulachev, V. P. Pro-grammed and altruistic ageing. Nat. Rev. Genet. 6, 866–72 (2005).

[13] de Magalhães, J. a. P. Programmatic features of agingoriginating in development: aging mechanisms beyondmolecular damage? FASEB J. 26, 4821–6 (2012). URLhttp://www.fasebj.org/content/26/12/4821.short.

[14] Orgel, L. E. Ageing of Clones of Mammalian Cells. Na-ture 243, 441–445 (1973).

[15] Hopfield, J. J. Kinetic Proofreading: A New Mechanismfor Reducing Errors in Biosynthetic Processes RequiringHigh Specificity. Proc. Natl. Acad. Sci. 71, 4135–4139(1974).

[16] Danchin, A. Natural selection and immortality.Biogerontology 10, 503–16 (2009).

[17] Kogan, V., Molodtcov, I., Menshikov, L. I., Reis, R. J. S.& Fedichev, P. Stability analysis of a model gene networklinks aging, stress resistance, and negligible senescence.arXiv preprint arXiv:1408.0463 (2014).

[18] Antoulas, A. C. Approximation of Large-Scale DynamicalSystems (SIAM, 2009).

[19] Pletcher, S. D. et al. Genome-wide transcript pro-files in aging and calorically restricted< i> drosophilamelanogaster</i>. Current Biology 12, 712–723 (2002).

[20] Avanesov, A. S. et al. Age-and diet-associatedmetabolome remodeling characterizes the aging processdriven by damage accumulation. eLife 3 (2014).

[21] Vaupel, J. W. et al. Biodemographic trajectories oflongevity. Science 280, 855–860 (1998).

[22] Horvath, S. Dna methylation age of human tissues andcell types. Genome biology 14, R115 (2013).

[23] Balleza, E. et al. Critical dynamics in genetic regulatorynetworks: examples from four kingdoms. PLoS One 3,e2456 (2008).

[24] Krotov, D., Dubuis, J. O., Gregor, T. & Bialek, W.Morphogenesis at criticality. Proceedings of the NationalAcademy of Sciences 111, 3683–3688 (2014).

[25] Fiedler, B. E. Handbook of Dynamical Systems, Volume2 (Gulf Professional Publishing, 2002).

[26] Seydel, R. Practical Bifurcation and Stability Analysis,vol. 1 (Springer Science & Business Media, 2009).

[27] Suzuki, M. Passage from an initial unstable stateto a final stable state. In Advances in ChemicalPhysics, Volume 46, 195–276 (John Wiley & Sons, 2009).URL http://books.google.com/books?hl=en&lr=&id=6uAY7tkKEVkC&pgis=1.

[28] The latter observation is supported by the analysis of therecent experiments in D. melanogaster, where transcrip-tional responses to different stress factors were found tocontain a good fraction of similar differentially expressedgenes both in the limit of nearly lethal [60] and weakstressors [48].

[29] Morse, C. Does variability increase with age? an archivalstudy of cognitive measures. Psychol Aging 8, 156–64(1993).

[30] Rother, P. The aging changes of biological variability(author’s transl). ZFA 33, 463–6 (1978).

[31] Khalyavkin, A. & Krutko, V. Aging is a simple de-privation syndrome driven by a quasi-programmed pre-ventable and reversible drift of control system set pointsdue to inappropriate organism-environment interaction.Biochemistry (Moscow) 79, 1133–1135 (2014).

[32] Arlia-Ciommo, A., Piano, A., Leonov, A., Svistkova, V.& Titorenko, V. I. Quasi-programmed aging of bud-ding yeast: a trade-off between programmed processesof cell proliferation, differentiation, stress response, sur-vival and death defines yeast lifespan. Cell Cycle 13,3336–3349 (2014).

[33] Blagosklonny, M. V. Answering the ultimate question"what is the proximal cause of aging?". Aging 4, 861–877(2012).

[34] Blagosklonny, M. V. Mtor-driven quasi-programmed ag-ing as a disposable soma theory. Cell Cycle 12, 1842–1847 (2013).

21

0 0.5 1 1.5 2

x 104

−0.6

−0.5

−0.4

−0.3

−0.2

−0.1

0

0.1

i

bi

50 100 150 200−0.05

0

0.05betaine

phosphocholine

histidine

C32:2 PC

acetylcarnitine

Figure 8: Components of the vector b for D. melanogaster, calculated from the full metabolic profiles (including alldetected targeted and non-targeted metabolites) from [20].

[35] Gompertz, B. On the nature of the function expressiveof the law of human mortality, and on a new mode ofdetermining the value of life contingencies. Philosophicaltransactions of the royal society of London 115, 513–583(1825).

[36] Gems, D. & Doonan, R. Antioxidant defense and agingin c. elegans: is the oxidative damage theory of agingwrong? Cell Cycle 8, 1681–1687 (2009).

[37] Tacutu, R. et al. Human ageing genomic resources: Inte-grated databases and tools for the biology and genetics ofageing. Nucleic acids research 41, D1027–D1033 (2013).

[38] Khan, I. & Prasad, N. The aging of the immune responsein drosophila melanogaster. The Journals of GerontologySeries A: Biological Sciences and Medical Sciences 68,129–135 (2013).

[39] Zhou, D. et al. Mechanisms underlying hypoxia tolerancein drosophila melanogaster: hairy as a metabolic switch.PLoS genetics 4, e1000221 (2008).

[40] Overschee, V. & Moor, D. Subspace Identification forLinear Systems: Theory, Implementation, Applications(Kluwer Academic, 1996).

[41] Ferguson, M., Mockett, R., Shen, Y., Orr, W. & Sohal, R.Age-associated decline in mitochondrial respiration andelectron transport in drosophila melanogaster. Biochem.J 390, 501–511 (2005).

[42] Poynter, M. E. & Daynes, R. A. Peroxisome proliferator-activated receptor α activation modulates cellular redoxstatus, represses nuclear factor-κb signaling, and reducesinflammatory cytokine production in aging. Journal ofBiological Chemistry 273, 32833–32841 (1998).

[43] Gómez-Valadés, A. G. et al. Overcoming diabetes-induced hyperglycemia through inhibition of hepaticphosphoenolpyruvate carboxykinase (gtp) with rnai.Molecular Therapy 13, 401–410 (2006).

[44] Blagosklonny, M. V. Validation of anti-aging drugs bytreating age-related diseases. Aging 1, 281 (2009).

[45] Budovskaya, Y. V. et al. An< i> elt-3/elt-5/elt-6</i>gata transcription circuit guides aging in< i> c. ele-gans</i>. Cell 134, 291–303 (2008).

[46] Hayflick, L. Entropy explains aging, genetic determinismexplains longevity, and undefined terminology explainsmisunderstanding both. PLoS Genet. 3, e220 (2007).

[47] Christensen, K., Doblhammer, G., Rau, R. &Vaupel, J. W. Ageing populations: the chal-lenges ahead. Lancet 374, 1196–208 (2009). URLhttp://www.sciencedirect.com/science/article/pii/S0140673609614604.

[48] Moskalev, A. et al. Mining gene expression datafor pollutants (dioxin, toluene, formaldehyde) and lowdose of gamma-irradiation. PLoS ONE 9, e86051(2014). URL http://dx.doi.org/10.1371%2Fjournal.pone.0086051.

[49] American medical association, resolution 420 (a-13):recognition of obesity as a disease. In Proceedings of theHouse of Delegates 162nd Annual Meeting (2013).

[50] Ren, C., Webster, P., Finkel, S. E. & Tower, J. In-creased internal and external bacterial load during< i>drosophila</i> aging without life-span trade-off. Cellmetabolism 6, 144–152 (2007).

[51] Finch, C. E. Longevity, senescence, and the genome (Uni-versity of Chicago Press, 1994).

[52] Buffenstein, R. The naked mole-rat: a new long-livingmodel for human aging research. The Journals of Geron-tology Series A: Biological Sciences and Medical Sciences60, 1369–1377 (2005).

[53] Kim, E. B. et al. Genome sequencing reveals insights intophysiology and longevity of the naked mole rat. Nature479, 223–227 (2011).

[54] Jeannette Loram, A. B. Age-related changes in gene ex-pression in tissues of the sea urchin< i> strongylocentro-tus franciscanus</i>. Mechanisms of Ageing and Devel-opment 133, 338–347 (2012).

22

pos neg

oxidation-reduction processresponse to stress

response to inorganic substancehumoral immune response

defense response

nucleoside triphosphate biosynthetic processpurine nucleoside triphosphate biosynthetic process

ribonucleoside triphosphate biosynthetic processpurine ribonucleoside triphosphate biosynthetic process

ATP biosynthetic processpurine nucleoside biosynthetic process

purine ribonucleoside biosynthetic processenergy coupled proton transport, down electrochemical gradient

ATP synthesis coupled proton transportpurine nucleoside monophosphate biosynthetic process

purine ribonucleoside monophosphate biosynthetic processglycosyl compound biosynthetic process

nucleoside biosynthetic processribonucleoside biosynthetic process

nucleoside monophosphate biosynthetic processribonucleoside monophosphate biosynthetic process

hydrogen ion transmembrane transporthydrogen transport

proton transportchorion-containing eggshell formation

eggshell formationpurine ribonucleotide biosynthetic process

purine nucleotide biosynthetic processribonucleotide biosynthetic process

ribose phosphate biosynthetic processpurine-containing compound biosynthetic process

nucleoside phosphate biosynthetic processnucleotide biosynthetic process

ATP metabolic processegg coat formation

vitelline membrane formation involved in chorion-containing eggshell formationvitelline membrane formation

purine nucleoside monophosphate metabolic processpurine ribonucleoside monophosphate metabolic process

nucleoside monophosphate metabolic processribonucleoside monophosphate metabolic process

proteolysisextracellular matrix assembly

organophosphate biosynthetic processinorganic cation transmembrane transport

inorganic ion transmembrane transportmitochondrial electron transport, cytochrome c to oxygen

monovalent inorganic cation transportpurine nucleoside triphosphate metabolic process

ribonucleoside triphosphate metabolic processpurine ribonucleoside triphosphate metabolic process

nucleoside triphosphate metabolic processcellular component assembly involved in morphogenesis

carbohydrate derivative biosynthetic processovarian follicle cell development

columnar/cuboidal epithelial cell developmentcolumnar/cuboidal epithelial cell differentiation

purine nucleoside metabolic processpurine ribonucleoside metabolic process

ribonucleoside metabolic processnucleoside metabolic process

glycosyl compound metabolic processepithelial cell development

purine ribonucleotide metabolic processpurine nucleotide metabolic processribose phosphate metabolic process

ribonucleotide metabolic processcation transmembrane transport

purine-containing compound metabolic processorganonitrogen compound biosynthetic process

oxidative phosphorylationsingle-organism biosynthetic process

protein localization to endoplasmic reticulumextracellular matrix organization

epithelial cell differentiationcation transport

nucleotide metabolic processnucleoside phosphate metabolic process

SRP-dependent cotranslational protein targeting to membrane, translocationnucleobase-containing small molecule metabolic processmitochondrial ATP synthesis coupled electron transport

ATP synthesis coupled electron transportion transmembrane transport

respiratory electron transport chaincarbohydrate derivative metabolic process

electron transport chaingeneration of precursor metabolites and energy

extracellular structure organizationfemale gamete generation

cell wall macromolecule catabolic processcell wall organization or biogenesis

cell wall macromolecule metabolic processorganophosphate metabolic process

epithelium developmention transport

cellular respirationeggshell chorion assembly

germ cell developmentoogenesis

developmental process involved in reproductiontransmembrane transport

cellular process involved in reproduction in multicellular organismenergy derivation by oxidation of organic compounds

ATP catabolic processpurine nucleoside monophosphate catabolic process

purine ribonucleoside monophosphate catabolic processmulti-organism process

nucleoside monophosphate catabolic processribonucleoside monophosphate catabolic process

gamete generationanatomical structure formation involved in morphogenesis

single organism reproductive processSRP-dependent cotranslational protein targeting to membrane

cotranslational protein targeting to membraneestablishment of protein localization to endoplasmic reticulum

protein targeting to ERprotein folding

intracellular protein transmembrane transportprotein targeting to membrane

ATerm-For-Term, biological processFrequency

2%4%6%8%10%

3.0

4.5

6.0

7.5

9.0

10.5

12.0

13.5

-log1

0(p-value)

pos neg

iron ion binding

oxidoreductase activity, acting on a heme group of donors

heme-copper terminal oxidase activity

structural constituent of chorion

structural constituent of egg coat

structural molecule activity

serine hydrolase activity

unfolded protein binding

B Parent-Child-Intersection, molecular function

3.5

4.0

4.5

5.0

5.5

6.0

6.5

-log1

0(p-value)

pos neg

extracellular region

external encapsulating structure

lipid particle

envelope

cytochrome complex

respiratory chain

C Parent-Child-Intersection, cellular component

4.5

6.0

7.5

9.0

10.5

12.0

13.5

15.0

-log1

0(p-value)

Figure 9: GO enrichment analysis of the leading gene compounds of the ageing direction, b. (A) Term-by-termresults summary, Biological Process only (cf to Figure 3a); Parent-Child-Intersection results, (B) Cellular

Compartment and (C) Molecular Function.

23

[55] Bauer, S., Gagneur, J. & Robinson, P. N. Going bayesian:model-based gene set analysis of genome-scale data. Nu-cleic acids research 38, 3523–3532 (2010).

[56] Grossmann, S., Bauer, S., Robinson, P. N. & Vingron,M. Improved detection of overrepresentation of gene-ontology annotations with parent–child analysis. Bioin-formatics 23, 3024–3031 (2007).

[57] Da Wei Huang, B. T. S. & Lempicki, R. A. System-atic and integrative analysis of large gene lists usingdavid bioinformatics resources. Nature protocols 4, 44–57(2008).

[58] Huang, D. W., Sherman, B. T. & Lempicki, R. A. Bioin-formatics enrichment tools: paths toward the compre-hensive functional analysis of large gene lists. Nucleicacids research 37, 1–13 (2009).

[59] Xia, J., Mandal, R., Sinelnikov, I. V., Broadhurst, D. &Wishart, D. S. Metaboanalyst 2.0-a comprehensive serverfor metabolomic data analysis. Nucleic acids research 40,W127–W133 (2012).

[60] Brown, J. B. et al. Diversity and dynamics of thedrosophila transcriptome. Nature (2014).

[61] Kadish, I. et al. Hippocampal and cognitive aging acrossthe lifespan: a bioenergetic shift precedes and increasedcholesterol trafficking parallels memory impairment. TheJournal of Neuroscience 29, 1805–1816 (2009).

[62] The number of different principal components PCn rep-resenting the signal x(t1), . . . , x(tm) does not exceed m.

[63] Schervish, M. J. Theory of Statistics, vol. 21 (SpringerNew York, 2011).

[64] In particular, the rate of these changes is limited by asingle gene transcription time, ∼ 1 min.

[65] In particular, they are not small at early times, close tothe initial state of the expressome.

[66] When higher order derivatives in Eq. (A1) are takeninto account, this argument, albeit becoming more in-volved, remains valid: one has to construct the pertur-bation theory in powers of small parameter ε, whichstill determines the smallest eigenvalue of the matrixA(f) = K + i2πfD + (2πf)2M + . . . . Similarly to thecase considered here, all higher eigenvalues of A(f) pos-sess positive real parts.

[67] Zwanzig, R. Nonequilibrium Statistical Mechanics (Ox-ford University Press, USA, 2001).

[68] Of course, albeit natural, this is still an assumption, asdifferent gene expressions are not truly independent GRNstate variables.

[69] Suzuki, M. Scaling theory of transient phenomena nearthe instability point. Journal of Statistical Physics 16,11–32 (1977). URL http://link.springer.com/10.1007/BF01014603.

[70] Redner, S. A Guide to First-Passage Processes (Cam-bridge University Press, 2001).

[71] Aalen, O., Borgan, O. & Gjessing, H. Survival and EventHistory Analysis: A Process Point of View (Springer,2008).

[72] Weitz, J. S. & Fraser, H. B. Explaining mortality rateplateaus. Proc. Natl. Acad. Sci. U. S. A. 98, 15383–6(2001).

[73] Steinsaltz, D. & Evans, S. N. Markov mortality mod-els: implications of quasistationarity and varying initialdistributions. Theor. Popul. Biol. 65, 319–37 (2004).

24

[Competing Interests] The authors declare that theyhave no competing financial interests.

[Author Contrbutions] All authors contributed equallyto this work.

[Correspondence] Correspondence and requests formaterials should be addressed to P.O.F. (email: pe-ter.fedichev@gmail.com) and D.P. (email: dpodol-skiy@research.bwh.harvard.edu).